Blog Category

Press Releases

Biophytis announces its participation in several events in Europe and the United States over the coming months

, , ,

/

12 March 2024

Biophytis presented the potential of Ruvembri™ in the treatment of Duchenne Muscular Dystrophy

,

/

8 March 2024

Publication of a book on medecine and science of longevity

,

/

22 February 2024

“Live healthier longer” – Publication of a book on the medicine and science of longevity

,

/

22 February 2024

Webcast of 17 January 2024 on our ambitions with Ruvembri® in respiratory viral infections

,

/

23 January 2024

Biophytis announces the publication of the results of its COVA phase 2-3 study in eClinicalMedicine, part of The Lancet

, , ,

/

4 January 2024

Biophytis announces the drawing of the fourth tranche of ORNANE under the 2021 Atlas Contract

,

/

29 December 2023

Biophytis announces its participation in several conferences in Europe and the US during the first quarter of 2024

, , ,

/

11 December 2023

Biophytis and the University of Liège explore the potential of Sarconeos (BIO101) in the treatment of viral respiratory failure

,

/

4 December 2023

Biophytis appoints Yann Meunier and Bernard Lévy to its Scientific Advisory Board

,

/

27 November 2023

Biophytis announces the success of its capital increase with preferential subscription rights for approximately €1.96 million

,

/

20 November 2023

Biophytis to attend BIO-Europe in Munich

, , ,

/

6 November 2023